6R8F image
Entry Detail
PDB ID:
6R8F
EMDB ID:
Title:
Cryo-EM structure of the Human BRISC-SHMT2 complex
Biological Source:
Source Organism:
Host Organism:
PDB Version:
Deposition Date:
2019-04-01
Release Date:
2019-06-05
Method Details:
Experimental Method:
Resolution:
3.80 Å
Aggregation State:
PARTICLE
Reconstruction Method:
SINGLE PARTICLE
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Lys-63-specific deubiquitinase BRCC36
Chain IDs:A, D (auth: C)
Chain Length:316
Number of Molecules:2
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Description:BRISC complex subunit Abraxas 2
Chain IDs:B, E (auth: D)
Chain Length:267
Number of Molecules:2
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Description:BRISC and BRCA1-A complex member 2,BRCC45 (BRE, BRISC and BRCA1-A complex member 2)
Chain IDs:G (auth: E), H (auth: G)
Chain Length:217
Number of Molecules:2
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Description:Serine hydroxymethyltransferase, mitochondrial
Mutations:A285T
Chain IDs:C (auth: K), F (auth: L)
Chain Length:504
Number of Molecules:2
Biological Source:Homo sapiens
Ligand Molecules
Primary Citation
Metabolic control of BRISC-SHMT2 assembly regulates immune signalling.
Nature 570 194 199 (2019)
PMID: 31142841 DOI: 10.1038/s41586-019-1232-1

Abstact

Serine hydroxymethyltransferase 2 (SHMT2) regulates one-carbon transfer reactions that are essential for amino acid and nucleotide metabolism, and uses pyridoxal-5'-phosphate (PLP) as a cofactor. Apo SHMT2 exists as a dimer with unknown functions, whereas PLP binding stabilizes the active tetrameric state. SHMT2 also promotes inflammatory cytokine signalling by interacting with the deubiquitylating BRCC36 isopeptidase complex (BRISC), although it is unclear whether this function relates to metabolism. Here we present the cryo-electron microscopy structure of the human BRISC-SHMT2 complex at a resolution of 3.8 Å. BRISC is a U-shaped dimer of four subunits, and SHMT2 sterically blocks the BRCC36 active site and inhibits deubiquitylase activity. Only the inactive SHMT2 dimer-and not the active PLP-bound tetramer-binds and inhibits BRISC. Mutations in BRISC that disrupt SHMT2 binding impair type I interferon signalling in response to inflammatory stimuli. Intracellular levels of PLP regulate the interaction between BRISC and SHMT2, as well as inflammatory cytokine responses. These data reveal a mechanism in which metabolites regulate deubiquitylase activity and inflammatory signalling.

Legend

Protein

Chemical

Disease

Primary Citation of related structures